Curebiotech, Inc

Neurokappa Therapeutics LLC is a Philadelphia-based company comprised of a team of scientists and business professionals dedicated to developing innovative medications for neurological diseases such as stroke, pain, and addiction. Leveraging their deep understanding of opioid receptors, they aim to create novel compounds that target these receptors, with potential therapeutic applications in stroke therapy, pain management, depression, and addiction therapy. The company's vision is to provide an effective alternative pathway for delivering medications for neurological diseases, particularly in out-of-hospital settings where intravenous access may not be readily available. With a focus on prioritizing the efficacy of action over the mechanism of actions, Neurokappa Therapeutics LLC is committed to continuously pursuing both scientific discoveries and the development of new indications for existing medications.Generated from the website

Ciscovery Bio Inc is a biotechnology company based in Philadelphia, PA. Specializing in research and development, the company focuses on innovative solutions in the field of bioengineering. With a team of dedicated scientists and experts, Ciscovery Bio Inc is committed to advancing scientific knowledge and exploring new possibilities in the realm of biotechnology. Generated from their business information

Longevity Biotech, Inc., based in Philadelphia, PA, is dedicated to advancing innovative solutions in the field of neurodegenerative diseases through its precision neuroscience approach. The company utilizes its proprietary Hybridtide Platform to develop therapies aimed at rebalancing the immune system and addressing conditions such as Parkinson's disease. With a strong leadership team and a network of scientific advisors, Longevity Biotech is committed to pioneering research and clinical trials that push the boundaries of current treatment methodologies. Their focus on precision approaches positions them at the forefront of biotechnology aimed at improving patient outcomes in neurodegenerative disorders. Generated from the website